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Abstract
The Expanded Program for Immunization Consortium – Human Immunology Project
Consortium study aims to employ systems biology to identify and characterize vaccine-induced
biomarkers that predict immunogenicity in newborns. Key to this effort is the establishment of
the Data Management Core (DMC) to provide reliable data and bioinformatic infrastructure
for centralized curation, storage, and analysis of multiple de-identified “omic” datasets. The
DMC established a cloud-based architecture using Amazon Web Services to track, store,
and share data according to National Institutes of Health standards. The DMC tracks biological
samples during collection, shipping, and processing while capturing sample metadata and asso-
ciated clinical data. Multi-omic datasets are stored in access-controlled Amazon Simple Storage
Service (S3) for data security and file version control. All data undergo quality control processes
at the generating site followed by DMC validation for quality assurance. The DMCmaintains a
controlled computing environment for data analysis and integration. Upon publication,
the DMC deposits finalized datasets to public repositories. The DMC architecture provides
resources and scientific expertise to accelerate translational discovery. Robust operations allow
rapid sharing of results across the project team.Maintenance of data quality standards and pub-
lic data deposition will further benefit the scientific community.
Introduction
As scientific technology advances and biomedical research emphasizes big data generation and
analysis, an increasing demand for powerful computing capabilities is expected [1]. Such
demands may be addressed by purchasing, supporting, and maintaining hardware locally, or
more traditionally by dedicated data centers which are costly to establish [2, 3]. There is an
unmet need for mid- to large-scale research programs that require customized data manage-
ment solutions but cannot afford a dedicated data center. Cloud computing has emerged as
an appealing approach because of its ease ofmaintenance, scalability, and on-demand character-
istics [3]. Cloud computing is a cost-effective alternative compared to physical hardware-based
computing [2]. Multiple backup systems ensure durability and reliability of data with scalability
according to demand [4]. Enhanced data security can be implemented internally using appli-
cation-level best practices while cloud providers enforce external policies [4]. With Findable,
Accessible, Interoperable, Reusable (FAIR) guidelines in mind [5], cloud-computing infrastruc-
ture can offer retrievable identifiers using standardized protocols with appropriate authentica-
tion procedures and ease in sharing data for scientific reproducibility. Efforts and infrastructure
to promote FAIR guidelines may in turn help address the perceived scientific crisis of repro-
ducible results which receives frequent comment [6]. As the scope, scale, and complexity
of research data increases, integration of computationally intensive data management and
biomedical research is likely [7]. The use of cloud computing plays
a key role in addressing issues related to traditional storage and
analysis of high-dimensional systems biology data [8].
Mid- to large-scale human biomedical studies, for example,
those with participants and samples in the hundreds to thousands
require a robust data infrastructure to track biological samples
along the experimental pipeline, curate and analyze the resulting
data files, and share data and results across an inter-disciplinary
project team [9]. The Precision Vaccines Program Data Manage-
ment Core (DMC), based at Boston Children’s Hospital, identified
these needs while planning the digital infrastructure to support the
Expanded Program for Immunization Consortium (EPIC). EPIC is
an international affiliation of biomedical centers partnering with
the aim of applying systems biology techniques using global
molecular tools to identify biomarkers that predict host response
to vaccination and/or mechanistic cause–effect of commonly
accepted correlates of protection. The initial pilot cohort, desig-
nated EPIC-001, demonstrated feasibility of a “small sample –
big data” approach using small volumes of human newborn
peripheral blood for onsite fractionation and cryopreservation
prior to shipment to end point assay laboratories [10]. EPIC
received additional funding from the Human Immunology Project
Consortium (HIPC), a program established by the National Insti-
tutes of Health (NIH)/National Institutes of Allergy and Infectious
Diseases (NIAID), to enroll a larger cohort designated EPIC-002
designed to characterize in vivo, in vitro, and in silico molecular
signatures that predict immunogenicity of hepatitis B vaccine in
early life.
The EPIC-HIPC project was organized with multiple cores
around the world working collaboratively to fulfill our specific
aims (Fig. 1), including an Administrative Core, a Clinical Core,
and several Service Cores to perform experimental assays including
a Proteomics Core (Boston, MA) and Transcriptomics Core
(Vancouver, BC). The DMC established three scientific aims
for this project: (1) create a project-wide secure data manage-
ment infrastructure; (2) provide a cloud-based scientific envi-
ronment to enable cross-platform bioinformatics and integrative
analyses; and (3) establish EPIC-HIPC-wide quality assurance (QA)
policies and standards for each data source. The DMC’s core func-
tional responsibilities included accurate and reliable data capture,
secure datamanagement, QA, project and analytic computing resour-
ces, and deposition of data to public repositories.
Amazon Web Services (AWS) offers an on-demand, scalable,
and secure cloud-computing platform which includes several ser-
vices to meet our project needs. For data storage, we used Amazon
Simple Storage Service (S3) which is an object storage service offer-
ing scalability and continuous data availability [11]. We used AWS
Elastic Compute Cloud (EC2), a service that provides secure and
web-scalable cloud computing, to host our software platforms, e.g.,
sample tracking software and analytic computing environment
[12]. Using AWS Identity and Access Management (IAM), we
managed user permissions and access and restricted the inbound
security groups with access to our EC2 instances [13].
Materials and Methods
We specified three core principles to guide DMC implementation
for the infrastructure design: data security, operational flexibility,
and affordability. Our design, based on these three main themes,
maintains a robust data platform that addresses unique project needs.
Data Security
Data security and privacy are critical concerns when managing
data from human study participants. In partnership with AWS,
our institution established a Business Associate Agreement (BAA)
Fig. 1. Global map of our Administrative, Clinical, Service, and Data Management Cores.
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allowing a regulated and secureAWS environment to process,main-
tain, and store protected health information, as required under
U.S. Health Insurance Portability and Accountability Act of 1996
rules [14]. Through AWS security features, we restricted access to
EPIC collaborators only using a controlled list of Internet Protocol
(IP) addresses. We further required user credentials specific for
each research teammember for each service used. For data storage,
the DMC architecture leveraged S3 as a local data repository. For
data integrity and version control, we designated permissions such
that only DMC administrators had download or deletion privi-
leges. All other project users had ‘push’ privileges only, i.e., users
could upload but not download or delete files. We installed a num-
ber of server-based software products maintained on EC2 virtual
instances. This design allowed us to maintain multiple software
and applications, store and share data securely, and scale or remove
instances as project computing needs changed. Each EC2 instance
or S3 bucket was assigned a security group which acted as a virtual
firewall to control all communications via a specified list of
inbound rules [15]. Secured access and central repository of all
datasets were managed by DMC staff. Data were secured through
encryption, controlled IP access, and user credentials.
Operational Flexibility and Low Cost
We intended our model to be adaptable and scalable to unforeseen
needs. Cloud computing offers a flexible approach to infrastructure
design to enable payment for services on-demand and to scale.
We designed the digital infrastructure to support EPIC-HIPC
studies around three broad categories of activity: data capture, data
processing, and data analysis (Fig. 2). We considered options for
computing platforms and software to achieve our design aims
and ultimately selected a system built upon AWS cloud-computing
Fig. 2. Overall data pipeline for the project. Clinical and sample data are generated and captured at the clinical site. Experimental assays are run inmultiple Service Cores. Each of
these sites and cores performs quality control (QC) as well as independent data analysis. All data transfers occur via S3. The DMC then performs quality assurance (QA) and uploads
the clean data to S3. Data are integrated on RStudio Server Pro and accessed on R Shiny application. Following publication of study output, data are deposited onto public
repositories, such as ImmPort and Gene Expression Omnibus. Note: This illustration does not necessarily depict chronological timelines as the data flow is often run in multiple
batches.
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architecture. This allowed us to self-service implementation and
maintenance of our system, using the AWS web-based graphical
interface for system configuration and administration. Integra-
tion of data storage with computing facilities was a useful feature
of AWS architecture. Cost estimates suggested that AWS would
provide a cost-effective solution relative to other options.
The main alternative to cloud computing that we considered
was local server hosting; yet, we found this option to be less effi-
cient andmore costly. A local server requires purchase and replace-
ment of hardware, skilled staff to configure and maintain the
system, and dedicated laboratory space to house hardware.
Moreover, such an approach would require an upfront investment
and routine maintenance throughout the project period, whereas
the pay-as-you-go approach of cloud computing incurred low
costs early in the project period during enrollment and sample
tracking. Because of the previously established BAA with our insti-
tution, AWS was a natural choice of platform to avoid the time and
expense and to establish the necessary agreements with another
cloud-computing service management company, e.g., Microsoft
Azure [16] or Google Cloud [17]. Our institution has a Research
Computing teamwith extensive AWS experience that provided sup-
port and advice during the design and deployment of our digital
infrastructure.
Data Capture
The clinical information and sample metadata were captured at the
clinical sites using electronic case report forms (eCRFs) and sample
processing forms (SPF), respectively. Data captured on the eCRFs
are described in our clinical protocol [18]. Metadata captured on
the SPF include basic sample metadata such as the date/time of
collection, study personnel involved in sample collection, and a
unique identifier used to link biosamples to clinical data.
Traditionally, clinical data were captured on paper case report
forms (CRFs); however, improvised eCRFs are now preferred [19].
Within the scope of our project, we captured clinical data in a
custom-built Research Electronic Data Capture (REDCap) data-
base [20, 21] designed and developed in collaboration with the
Clinical Core. REDCap is a secure, web-based software platform to
support data capture for research studies, providing (1) an intuitive
interface for validated data capture; (2) audit trails for tracking data
manipulation and export procedures; (3) automated export proce-
dures for seamless data downloads to common statistical packages;
and (4) procedures for data integration and interoperability with
external sources [20, 21]. Although REDCap has the technical means
to provide compliance with FDA 21 CFR Part 11, we did not imple-
ment those features in this study [21, 22]. There aremany alternatives
to REDCap, e.g., Studytrax [23] and InForm Electronic Data Capture
[24]. Our decision relied on the academic availability and current
implementation across our institution and the clinical sites at The
Gambia and Papua New Guinea.
After collecting biological samples at the clinical sites, we tracked
each sample point-to-point with commercial software ItemTracker
[25] implemented via user-accessible Windows remote desktop
or web-based application, both of which store data on a
Microsoft SQL database hosted on an EC2 instance. We updated
ItemTracker with the sample infrastructure defining each entry
using preloaded numerical item identifiers for participants. We
uploaded sample label sets, consisting of predefined study visit
sets, into a project-specific ItemTracker configuration. Each study
visit set was uniquely identified using a randomized four-digit
alpha-numeric visit identifier. All samples were assigned a unique
item identifier at the time of ItemTracker upload. We provided
clinical sites with unassigned sample label sets for sample collec-
tion. Preprinted labels included information on the type of sample,
the unique alpha-numeric visit identifier, and a scannable Quick
Response (QR) code with embedded identifier data. We captured
sample metadata (e.g., time of collection, plasma volume, labora-
tory technician initials) and linkage between the sample and sub-
ject identifier on paper SPFs which we entered manually into
ItemTracker.
The DMC used ItemTracker to track all biological specimens as
they were shipped from clinical sites to Service Cores. Sample loca-
tions were updated by scanning a QR code on a box of samples or the
sample tube itself. As boxes of sampleswere shipped, theywere placed
in an “In Transit” folder which was then updated upon delivery and
receipt. The samples were initially stored in the order they were col-
lected, but once they reached the Service Cores, they were sorted
chronologically following a sorting map generated by the DMC.
Sample locations were tracked using a multi-level hierarchy
including site, building, room, storage freezer, storage shelf, storage
rack, storage column, box number, and position within box (Fig. 3).
Once the samples reached their final destination and were sorted,
Service Cores ran each sample through experimental assay pipelines.
EPIC-HIPC collaborators conductedmultiple assays including tran-
scriptomics, proteomics, flow cytometry, and antibody titers within
dedicated Service Cores (Fig. 1).
Data Processing
Effective data management is essential to make data discoverable,
accessible, and understandable [26]. Each Service Core specified
and performed data curation according to each data type and gen-
erated initial quality flags for data analysis. To clearly define our
terminology, quality control (QC) refers to the local processes to
establish data quality standards performed at the Service Cores,
while QA is the central process to verify and ensure data quality
by the DMC.
Once the data completed local QC, core and site researchers
uploaded data to the S3 directory, including associated “readme”
text files to explain the format and contents of each data file.
There were data validation checks embedded into the REDCap
data capture system to identify and flag missing or out-of-range
values. The DMC performed additional QA processes to all clini-
cal, sample, and experimental data. QA was specific to each data
type, and generally included quality checks across the following
themes: verifying QC processes, checks for missing values, identi-
fication and investigation of outliers, chronologic deviations, i.e.,
date and time measures, and protocol deviations. Through the
QA process, the DMC generated relevant flags for data analysts
and then uploaded the final datasets to S3.
As QA was completed, data are deposited in real time to public
repositories (e.g., ImmPort [27] and Gene Expression Omnibus
[28]), set for public release upon publication. For example, the data
fromEPIC-001 are available at ImmPort (immport.org) under study
accession SDY1256 and SDY1412 [10, 27]. The DMC established
consistent file naming conventions for each data type to ensure
standardization and reproducibility, setting guidelines of good prac-
tice and facilitating the deposition of data to public repositories in
order to maximize benefit to the broader scientific community.
Data Analysis
TheDMC supports project cores and scientists responsible for data
analysis. All project analysts used RStudio Server Pro hosted on an
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EC2 instance [29]. This analytic platform seamlessly integrated
data stored on S3 for a controlled repository and cloud-computing
environment that ensured repeatable and reproducible results.
Data visualization is crucial to convey results and information,
yet not all project scientists had the computing experience to con-
duct analyses directly from raw data. RShiny, a user-friendly appli-
cation, allows scientists to visualize data interactively from a
centralized platform [30]. We included a variety of widgets to
empower the users to control their visual outputs, e.g., radio but-
tons or drop-down menus to select from a list of analytic options.
Using these widgets, the users specified graphical outputs such as
color graphs of specified data sources. We further added a feature
to allow users to hover over a point of interest in a graph and return
a table providing the data associated to said point. The RShiny
application was hosted on an EC2 instance with a security group
containing specified inbound rules.
Results
We implemented ItemTracker to track over 45,000 tubes contain-
ing human samples collected and shipped internationally for our
cohort in The Gambia (n= 720). Initially, we hosted the software
on a Windows m4.large instance (two virtual central processing
units (vCPUs) and eight GiB memory). Once we reached comput-
ing capacity, noted by lag and latency experienced by simultaneous
users, we upgraded the instance to m4.xlarge (4 vCPU and 16 GiB
memory). We uploaded all study data to designated S3 directories
that linked reliably with the RStudio Server Pro platform hosted on
an EC2 instance. Overall storage accounted for over 100,000 data
files with an estimated two terabytes of storage. Similarly, our com-
puting instance that hosted RStudio Server Pro initially used a
Linux m4.large instance (2 vCPUs and 8 GiB memory). As our
computing needs expanded, we upgraded to m5.xlarge (4 vCPUs
and 16 GiB memory). We added capabilities to provide additional
short-term resources for time-limited high-intensity computing.
For example, a single run of a biomarker discovery pipeline might
require dozens of processing cores and an order of magnitude
increase in memory allocation over a period of 1–2 weeks. By
allowing time-flexible scalability in both directions, we avoided
costly investments in server architecture, while maintaining local
control of a dedicated environment rather than relying on a shared
resource such as a high-performance cluster. To further reduce
cost, we scheduled EC2 instances to deactivate outside of typical
working hours.
To prioritize our QA activities, we categorized the clinical data
into four categories:
• DMC-internal clinical data are used for variable derivation and/
or QA purposes – e.g., date and time stamps or inclusion and
exclusion criteria.
• Tier 1 clinical data are critical to answer proposed primary
study questions – e.g., randomization group assignment or bio-
logical sex.
• Tier 2 clinical data are question-specific data – e.g., breastfeeding
status.
• Tier 3 clinical data are exploratory data – e.g., physical assess-
ment of neonate.
Throughout our comprehensive QA processes, we generated
multiple queries to ensure data quality available to researchers.
For example, for the Tier 1 and DMC-internal clinical data encom-
passing 177 variables (columns) for 720 subjects (rows), we gener-
ated eight data quality reports over 9 months, containing 149
queries, and 82 of these queries (55%) led to data changes. The
timeline for data to complete QA was dependent on various fac-
tors, e.g., when the data files were received, the QC process of
the associated Service Core, the quality level of the resulting data,
the size of the data, the QA processes performed on a specific type
of data, the response time toQA queries, and the overall bandwidth
of the DMC as we processed multiple datasets simultaneously.
Conducting diligent QC/QA processes according to a standard
protocol maintained high data quality while creating notable pres-
sure to meet expected timelines. The DMC worked efficiently to
balance timelines with data quality. For example, we defined tiers
of clinical data to prioritize QA and expedite data availability such
that the most important subsets of clinical data moved through our
QA process immediately while ancillary variables were deferred.
Similarly, we established a high priority to complete QA for exper-
imental assay data as it became available to enable ongoing data
analysis.
We trackedmonthly costs associated with the study’s data infra-
structure throughout the course of the project (Fig. 4). During the
period of clinical cohort enrollment and sample tracking, monthly
costs remained below $300 USD. There were additional fixed costs
for the sample tracking database below $5k USD per year. As the
project team engaged inmore data analysis,monthly costs increased.
Fig. 3. The multi-level location hierarchy established in ItemTracker. The example above illustrates a biological sample with its location coded as: BCH/HIM 8_Freezer_CRR-548/
Shelf 2 Rack 2/Column 1/PL-SORTED-001/5/4/E4.
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The DMC conducted development and user testing of the shared
analytic resources during projectmonths 16 to 23. Starting in project
month 24, analytic usage increase and monthly costs grew accord-
ingly. During these periods, there were additional fixed annual costs
for computing software licenses below $10k USD per year.
Discussion
The DMC established and maintained a cloud-based discovery
environment, consisting of data storage and computational tools
to perform integrative systems analyses and facilitate collaborations
between the projects and cores. Dealing with design complexity and
implementation of this infrastructure, we experienced several
challenges.
Tracking of biological samples using ItemTracker seemed
straightforward; however, when faced with real-world conditions,
we saw inevitable complications. Due to the nature of the sample
collection, processing, and storage, timeliness of processing
affected sample integrity. We updated the sample processing pro-
tocol to allow faster sample storage at the clinical sites. The status of
samples was updated manually after experimental assays were
processed, which made it difficult to maintain accurate status
updates in real time. DMC staff addressed this challenge with fre-
quent communication to cores and subsequent data queries during
QA once it was clear that sample locations were out of date. We
delivered additional training to sites on study processes and the
use of the tracking platform to ensure all updates were performed
according to protocol. Non-project research staff at some sites
occasionally relocated sample boxes, leading to further location
data inaccuracies. We addressed this issue with a dedicated freezer
area for the project at sites where this was feasible. Overall, the
DMC identified operational challenges and partnered with the core
sites to solve or mitigate these issues.
Implementation of RStudio as the primary software platform to
analyze project data posed a collaborative challenge. While most
data analysts were comfortable with the platform, some of the
project-affiliated biomedical researchers were not familiar with
the R programming language. The DMC developed an RShiny
application with pre-generated graphical outputs to allow for data
exploration and visualization. The application’s interactive fea-
tures allowed researchers without coding experience to perform
predefined analyses and visualizations – e.g., plotting data by bio-
logical sex. The DMC intends to develop and integrate other
software platforms to broaden the usability of the architecture out-
side of those analysts familiar with R.
When providing computing support for the smaller pilot cohort
(EPIC-001, n= 30, 2 timepoints) [10], we used a decentralized
model that allowed analysts the convenience of directly accessible
data. This decentralization resulted in naming inconsistencies and
versioning conflicts across multiple instances of data files. This
posed challenges to the QA process, verification of analyses for
purposes of reproducibility, and the eventual process of data dep-
osition. The loss of central control over data files had further impli-
cations for data security.
Throughout the conception and design of the data architecture
for our main study cohort (n= 720), the DMC maintained data
governance focusing on a centralized model for data access and
management. Although data security was a prominent feature in
our design, there were consequent trade-offs with data accessibil-
ity. The flexibility of our infrastructure allowed us to balance these
competing principles. We set a clear framework for implementa-
tion and communicated our core principles to the project team
while responding to feedback from users.
ItemTracker deployed on AWS platform proved to be a robust
and reliable software platform as demonstrated by the large quantity
of biological samples tracked. We implemented a hybrid approach
for QC/QA which decentralized QC and centralized QA. We relied
on the scientific expertise of each Service Core to performQC locally
and provide data of high quality to the DMC. Each core offered rec-
ommendations for additional QA by the DMC and feedback to
improve the process. This additional layer of QA improved the over-
all quality of the data and analytic pipeline, as evident by the number
of queries submitted and eventual data edits.
A notable limitation of our design was the lack of consistent
metadata capture related to DMC operations. Although we col-
lected limited data on key performance measures as reported
above, we did not have reliable capture of personnel time spent
on specific processes, nor did we establish a systematic approach
to classify QA queries and their resolutions. We have encountered
some resistance to strict adoption of our infrastructure and guide-
lines for use, as is often the case with large collaborative scientific
projects. Implementation challenges demonstrated the complexity
of our application.We believe our design offered flexibility and bal-
anced usability while staying faithful to our core principles.
Our experience suggests that cloud computing is a suitable
approach for mid-scale collaborative projects with modest finan-
cial budgets. Scientific endeavors of this scope/scale require robust
Fig. 4. Cloud computing costs over the first 31 months of the EPIC-HIPC project. The starting date is August 2017.
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data management plans, infrastructure, and operations. Imple-
menting centralized data governance with selected decentralized
operations proved a feasible and flexible approach that provided
both data security and accessibility.We believe our approach offers
advantages over a more traditional server-based architecture, most
notably an efficient and effective computing environment for inte-
grative analyses and scientific discovery.
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